Jim Simons Palatin Technologies Inc Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.5 $48,708 - $90,200	180,400 Added 387.96%	226,900 $64,000
Q1 2022 May 13, 2022	BUY	$0.37 - $0.54 $17,205 - $25,110	46,500 New	46,500 $21,000
Q1 2021 May 13, 2021	SELL	$0.68 - $1.25 $44,608 - $82,000	-65,600 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.38 - $0.78 $24,928 - $51,168	65,600 New	65,600 $44,000
Q3 2020 Nov 13, 2020	SELL	$0.47 - $0.64 $77,221 - $105,152	-164,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.41 - $0.73 $67,363 - $119,939	164,300 New	164,300 $84,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.7M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.